跳至主要内容
临床试验/NCT03363828
NCT03363828已完成不适用

The Temporo-spatial Dynamics of Genital Tract Microbiota - an Observational Study in IVF-Freeze All Patients Treated With Estradiol

Peter Humaidan2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2017年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
27
试验地点
2
主要终点
Rate of ascending infection/sharing of bacteria in the genital tract

研究概览

简要总结

The investigators aim to examine the endometrium with state of the art sequencing techniques to investigate the endometrial microbiota. The endometrial microbiota has been perceived to be sterile, however, this seems incorrect from recent studies. Thus, the primary outcome is to compare the rate of ascending infection from the semen to the vagina to the endometrium and to investigate which bacteria are capable of inhabiting these environments. Furthermore, cervical mucus will be obtained in order to test for immunological, microbiological and mechanical properties that may be involved in ascending infection. Finally, the study aim to characterize the temporal changes in the vaginal microbiota during estrogenic treatment with Estrofem® or Vivelle Dot (R) for preparation of the endometrium prior to embryo transfer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in IVF Freeze-all/segmentation treatment protocol.
  • Written informed consent.

排除标准

  • Uterine malformations
  • HIV, Hepatitis B or C positivity. HPV CIN 2 or higher. Chlamydia trachomatis positivity.
  • Any uncontrolled concomitant disease (e.g. uncontrolled diabetes, uncontrolled hypertension etc.)

研究组 & 干预措施

Abnormal microbiota

Based on qPCR and Next gen sequencing

干预措施: Estrofem (Drug)

结局指标

主要结局

Rate of ascending infection/sharing of bacteria in the genital tract

时间窗: This outcome data is measured at the day of oocyte retrieval.

Seminal, vaginal, cervical and endometrial samples will be compared at the time of oocyte retrieval.

次要结局

  • Number of participants with a Clinical pregnancy(7-9 weeks after inclusion.)
  • Next generation sequencing techniques will be used to assess the vaginal microbiota.I.e. measure of relative abundances(Examined longitudinally throughout the segmentation cycle. The estimated time to event is 40 days from oocyte retrieval until frozen embryo transfer following a strict protocol.)
  • qPCR to assess the vaginal microbiota. I.e. a quantitative measure Copies/mL.(Examined longitudinally throughout the segmentation cycle. The estimated time to event is 40 days from oocyte retrieval until frozen embryo transfer following a strict protocol.)
  • Number of participants with a Live birth(36-42 weeks after inclusion)

研究者

发起方
Peter Humaidan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Peter Humaidan

Professor

Regionshospitalet Viborg, Skive

研究点 (2)

Loading locations...

相似试验